Abstract
Chagas Disease is a parasitic infection caused by the T. Cruzi parasite endemic to Central and South America and transmitted through contact with Triatomine insects, commonly known as “kissing bugs.” Although the symptoms of Acute Chagas Disease (ACD) are nonspecific, untreated chronic infection can lead to heart disease, enlarged esophagus and colon, and stroke. Chagas disease has become increasingly rare owing to a series of public health interventions, including insect eradication campaigns in Brazil through the 1980’s that considerably reduced the number of new acute cases. However, hundreds of new acute cases still are diagnosed annually, primarily in the states of Pará, Amapá, and Acre. Moreover, the population in areas of high Chagas endemicity are changing: many areas are growing and becoming increasingly urban, whereas others are decreasing in population. We estimate the Incidence Rate (IR) for Acute Chagas disease over the period 2001-2019 in Brazil at the municipal level and investigate the variation of these rates with climatic factors. These estimates are used to project forward incidence of Acute Chagas Disease over the following decade 2020-2029. Modeling ACD presents numerous methodological challenges since incidence is rare, with extreme overdispersion of zero-case counts, and vectors exhibit a highly spatially- and temporally-clustered pattern. We use a spatially- and temporally-autoregressive small-area smoothing models to estimate the true latent risk in developing Acute Chagas Disease. The Bayesian model presented here involves spatio-temporal smoothing via a Zero-Inflated (Lambert 1992), Knorr-Held (2000)-Type spatio-temporal model with a BYM2 (Morris, 2019) spatial convolution to predict smoothed incidence rates of Chagas disease. As well, we include estimates of Brazil’s growing population and projected bioclimate to evaluate how climate and population change may affect ACD rates. We estimate that cases will continue to increase in the absence of control efforts, primarily driven by a growing peri-urban population in regions of Chagas endemicity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.